Infinite Biomedical Technologies Releases Innovative New Technology for Prosthetic Limb Control

Share Article

The new technology, MORPH, interfaces with most commercially available prosthetic hand and wrists on the market.

Infinite Biomedical Technologies, LLC (IBT), a client company in Baltimore City’s Emerging Technology Center (ETC), announced the release of its MORPH™ technology – an innovative new controlling technology for upper limb myo-electric prosthetics that interfaces with most commercially available prosthetic hand and wrists on the market, and is fully compatible with legacy switching methodologies. There are over 100,000 people in the US living with an upper limb amputation who can now potentially benefit from near perfect reliability in the switching of hand and wrist functions.

“The prosthetic hand that I had been using was nothing but an interesting toy – with the MORPH™ controller it has become a reliable tool,” says Sean McHugh, an early adopter of the MORPH™ technology. “I'm not sure how to convey the magic in this device – suddenly, there is hope for a bright new future that I had only dreamed would arrive!”

The award winning MORPH™ technology is unique in its full integration with wireless RFID tagging and Bluetooth interfacing technologies. The user no longer has to use EMG triggers to switch between functions; instead, RFID tags, which can be placed essentially anywhere, allow for convenient switching of functions. MORPH™ can also be used to turn off EMG inputs in order to maintain a constant grip and can be reprogrammed via a Bluetooth connection using a simple user interface.

“We are thrilled to be able to bring this significant advancement to users of upper limb prosthetics,” says Dr. Rahul Kaliki, CEO of IBT. “MORPH™ is already FDA approved and is produced under strict quality control guidelines to ensure a high quality, long lasting product.”

About IBT

IBT is a medical device company dedicated to creating innovative and useful solutions in prosthetic technology. The Company’s vision is to solve important prosthetic problems through first-hand feedback and by translating our research discoveries into prosthetic products through commercialization. Their mission is to become the leader in pushing the boundaries of new technologies for upper and lower limb prosthetics. For more information go to

About the ETC

ETC is a non-profit business incubator focused on growing early-stage technology and biotechnology companies. Since 1999 ETC has provided assistance to nearly 300 companies – 85% are still in business. These companies have received over $1.5 billion in outside funding and have created in excess of $375 million in positive economic impact on the City of Baltimore. For more information go to

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rahul Kaliki